New Orleans, LA, United States of America

William Alworth


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of William Alworth

Introduction

William Alworth is a notable inventor based in New Orleans, LA (US). He has made significant contributions to the field of cancer prevention through his innovative research and patents. His work focuses on the use of eugenol in combination with other chemopreventative agents, showcasing his commitment to advancing medical science.

Latest Patents

William Alworth holds a patent for the "Use of eugenol in combination with other chemopreventative agents as prophylaxis for cancers." This patent specifically addresses the use of eugenol, both alone and in combination with 2-methoxyestradiol (2-ME), in the context of prostate cancer prophylaxes and treatment. His innovative approach aims to provide new avenues for cancer prevention and treatment.

Career Highlights

Alworth is associated with Oncology Sciences Corporation, where he applies his expertise in oncology and chemoprevention. His work at the company reflects his dedication to improving cancer treatment options and enhancing patient outcomes. With a patent portfolio that includes one significant patent, he continues to contribute to the field of medical research.

Collaborations

Throughout his career, William Alworth has collaborated with esteemed colleagues such as Thomas J. Slaga and Addanki P. Kumar. These partnerships have allowed him to expand his research and explore new possibilities in cancer prevention.

Conclusion

William Alworth's innovative work in the field of cancer prevention highlights his commitment to advancing medical science. His patent on the use of eugenol in cancer prophylaxis represents a significant contribution to oncology. Through his career at Oncology Sciences Corporation and collaborations with other experts, he continues to make strides in improving cancer treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…